| Interleukin-13: central mediator of allergic asthma M Wills-Karp, J Luyimbazi, X Xu, B Schofield, TY Neben, CL Karp, ... Science 282 (5397), 2258-2261, 1998 | 3411 | 1998 |
| Immunologic basis of antigen-induced airway hyperresponsiveness M Wills-Karp Annual review of immunology 17 (1), 255-281, 1999 | 1372 | 1999 |
| The germless theory of allergic disease: revisiting the hygiene hypothesis M Wills-Karp, J Santeliz, CL Karp Nature Reviews Immunology 1 (1), 69-75, 2001 | 1100 | 2001 |
| Interleukin‐13 in asthma pathogenesis M Wills‐Karp Immunological reviews 202 (1), 175-190, 2004 | 985 | 2004 |
| Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein A Trompette, S Divanovic, A Visintin, C Blanchard, RS Hegde, R Madan, ... Nature 457 (7229), 585-588, 2009 | 897 | 2009 |
| Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. SH Gavett, DJ O'Hearn, X Li, SK Huang, FD Finkelman, M Wills-Karp The Journal of experimental medicine 182 (5), 1527-1536, 1995 | 774 | 1995 |
| Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. SH Gavett, X Chen, F Finkelman, M Wills-Karp American journal of respiratory cell and molecular biology 10 (6), 587-593, 1994 | 630 | 1994 |
| Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production D Kuperman, B Schofield, M Wills-Karp, MJ Grusby The Journal of experimental medicine 187 (6), 939-948, 1998 | 595 | 1998 |
| IL-4 and IL-13 signaling in allergic airway disease N Gour, M Wills-Karp Cytokine 75 (1), 68-78, 2015 | 561 | 2015 |
| CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function IP Lewkowich, NS Herman, KW Schleifer, MP Dance, BL Chen, ... The Journal of experimental medicine 202 (11), 1549-1561, 2005 | 550 | 2005 |
| A role for immune complexes in enhanced respiratory syncytial virus disease FP Polack, MN Teng, P L. Collins, GA Prince, M Exner, H Regele, ... The Journal of experimental medicine 196 (6), 859-865, 2002 | 486 | 2002 |
| Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma CL Karp, A Grupe, E Schadt, SL Ewart, M Keane-Moore, PJ Cuomo, ... Nature immunology 1 (3), 221-226, 2000 | 476 | 2000 |
| Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy F Adhami, G Liao, YM Morozov, A Schloemer, VJ Schmithorst, JN Lorenz, ... The American journal of pathology 169 (2), 566-583, 2006 | 470 | 2006 |
| Elevated cytokine levels in children with autism spectrum disorder CA Molloy, AL Morrow, J Meinzen-Derr, K Schleifer, K Dienger, ... Journal of neuroimmunology 172 (1-2), 198-205, 2006 | 446 | 2006 |
| Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway CL Karp, LM Flick, KW Park, S Softic, TM Greer, R Keledjian, R Yang, ... Nature immunology 5 (4), 388-392, 2004 | 429 | 2004 |
| Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma S Lajoie, IP Lewkowich, Y Suzuki, JR Clark, AA Sproles, K Dienger, ... Nature immunology 11 (10), 928-935, 2010 | 419 | 2010 |
| Importance of cytokines in murine allergic airway disease and human asthma FD Finkelman, SP Hogan, GKK Hershey, ME Rothenberg, M Wills-Karp The Journal of Immunology 184 (4), 1663-1674, 2010 | 371 | 2010 |
| Untangling the complex web of IL-4–and IL-13–mediated signaling pathways M Wills-Karp, FD Finkelman Science signaling 1 (51), pe55-pe55, 2008 | 326 | 2008 |
| Regulation of angiogenesis by a non-canonical Wnt–Flt1 pathway in myeloid cells JA Stefater III, I Lewkowich, S Rao, G Mariggi, AC Carpenter, AR Burr, ... Nature 474 (7352), 511-515, 2011 | 324 | 2011 |
| IL-12/IL-13 axis in allergic asthma M Wills-Karp Journal of Allergy and Clinical Immunology 107 (1), 9-18, 2001 | 324 | 2001 |
